SIRT1 and metabolic dysfunction-associated steatotic liver disease: Our previous studies indicated that alpha-lipoic acid (ALA), a powerful antioxidant, ameliorates NAFLD and improves hepatic lipid metabolic syndrome by inducing the SIRT1/AMPK pathway in vivo and in vitro7, 8.